Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Your Filters

Geographic : mexico Filter by : Subject

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Relative bioavailability and pharmacokinetic comparison of a fixed-dose combination tablet of mosapride, pancreatin, and simethicone relative to single-component mosapride tablets in healthy Mexican subjects.

Authors : Camarillo Cárdenas KP; Clinical Pharmacology Department, Avant Santé Research Center S.A. de C.V. Nuevo León, San Pedro Garza García, Mexico.; García González J

Subjects: Pancreatin* ; Simethicone*; Area Under Curve

Source: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Apr; Vol. 36 (2), pp. 427-435. Date of Electronic Publication: 2021 Dec 08.Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Read Online Read More Add to Saved list

Academic Journal

Cultural factors related to adherence to imatinib in CML: a Mexican perspective.

Authors : Cantú-Rodríguez OG; Sánchez-Cárdenas M; Gutiérrez-Aguirre CH

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Benzamides/Benzamides/Benzamides/*therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy

Source: Hematology (Amsterdam, Netherlands) [Hematology] 2015 Mar; Vol. 20 (2), pp. 72-6. Date of Electronic Publication: 2014 Jul 18.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Read Online Read More Add to Saved list

Academic Journal

Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia.

Authors : Gutierrez-Aguirre CH; Servicio de Hematología, Hospital Universitario ‘Dr. José Eleuterio González’-UANL, Mexico.; Garcia-Rodriguez F

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Benzamides/Benzamides/Benzamides/*therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy

Source: Hematology (Amsterdam, Netherlands) [Hematology] 2013 Jul; Vol. 18 (4), pp. 224-9. Date of Electronic Publication: 2013 Feb 20.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Read Online Read More Add to Saved list

Academic Journal

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Authors : Ruiz-Argüelles GJ; Centro de Hematología y Medicina Interna, Clinica Ruiz, Puebla, México. ; Tarin-Arzaga LC

Subjects: Hematopoietic Stem Cell Transplantation*; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*therapy

Source: Bone marrow transplantation [Bone Marrow Transplant] 2008 Jul; Vol. 42 (1), pp. 23-8.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

Read Online Read More Add to Saved list